| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |